Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease

Nephrology

Volumn 12, Issue 3, 2007, Pages 289-293

  Bellini, Maria H ^a,b   Figueira, Márcia N ^a   Piccoli, Michelly F ^a   Marumo, Júlio T ^b   Cendoroglo, Maysa S ^a   Neto, Miguel C ^a   Dalboni, Maria A ^a   Batista, Marcelo C ^a   Goes, Miguel  ^a   Schor, Nestor ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

27 bp repeats in intron 4; Chronic renal failure; Diabetes mellitus; End stage renal disease; Endothelial nitric oxide synthase; Gene polymorphism

Indexed keywords

DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA ISOLATION; FEMALE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; INTRON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTRONS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 34248177806     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00787.x     Document Type: Article

References (24)

1. Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 2000 4 : 241 451.
2. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 1996 1 : 41 5.
3. Noiri E, Satoh H, Taguchi J et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 2002 40 : 535 40.
4. Morishita T, Tsutsui M, Shimokawa H et al. Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc. Natl. Acad. Sci. USA 2005 30 : 10616 21.
5. Fagan KA, Morrissey B, Fouty BW et al. Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension. Respir. Res. 2001 5 : 306 513.
6. Devuyst O. Variable renal disease progression in autosomal dominant polycystic kidney disease: A role for nitric oxide. J. Nephrol. 2003 3 : 449 52.
7. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: Structure, function and inhibition. Biochem. J. 2001 3 : 593 615.
8. Nagase S, Suzuki H, Wang Y et al. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol. Cell. Biochem. 2003 244 : 113 18.
9. Dusserre N, L'Heureux N, Bell KS et al. PECAM-1 interacts with nitric oxide synthase in human endothelial cells: Implication for flow-induced nitric oxide synthase activation. Arterioscler. Thromb. Vasc. Biol. 2004 10 : 1796 802.
10. Buraczynska M, Ksiazek P, Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol. Dial. Transplant. 2004 9 : 2302 6.
11. Kurata H, Takaoka M, Kubo Y et al. Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction. Eur. J. Pharmacol. 2005 11 : 232 9.
12. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 2000 2 : 405 13.
13. Wang Y, Kikuchi S, Susuki H, Nagase S, Koyama A. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases. Nephrol. Dial. Transplant. 1999 14 : 2898 902.
14. Miyamoto Y, Saito Y, Kajiyama N et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998 1 : 3 8.
15. Yokoyama K, Tsukada T, Matsuoka H, Hara S, Yamada A, Kawaguchi Y. High accumulation of endothelial nitric oxide synthase (ecNOS): A gene polymorphism in patients with end-stage renal disease. Nephron 1998 3 : 360 61.
16. Marroni AS, Metzger IF, Souza-Costa DC et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 2005 3 : 177 82.
17. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001 8 : 719 25.
18. Mcclellan MW, Flanders DW. Risk factors for progressive kidney disease. J. Am. Soc. Nephrol. 2003 14 : S65 S70.
19. Ghiadoni L, Cupisti A, Huang Y et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J. Nephrol. 2004 4 : 512 19.
20. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW. Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol. Dial. Transplant. 2000 11 : 1794 800.
21. Tsukada T, Yokoyama K, Arai T et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 1998 1 : 190 93.
22. Neugebauer S, Baba T, Watanabe T. Association of nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 2000 49 : 500 503.
23. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Abnormalities in the renal and vascular responses to LBNP in humans with early diabetes. Am. J. Physiol. 1994 266 : R442 50.
24. Asakimori Y, Yorioka N, Yamamoto I et al. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron 2001 2 : 219 23.